omniture
logo
Search
JUNIPER BIOLOGICS
Media Room

Latest News

rss

Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards

SINGAPORE, April 18, 2024 /PRNewswire/ -- Juniper Biologics

2024-04-22 09:00 973

Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards

SINGAPORE, April 22, 2024 /PRNewswire/ -- Juniper Biologics

2024-04-22 09:00 1081

Advancing Healthcare Innovation: Juniper Biologics Recognized as the Best Novel Therapy R&D and Commercialization Company 2024 by APAC Insider

SINGAPORE, March 25, 2024 /PRNewswire/ -- Juniper Biologics

2024-03-25 09:51 768

Juniper Biologics Clinches Prestigious Molecular Science & Technology Acquisition of the Year Award at the Acquisition International M&A Awards 2023

SINGAPORE, Jan. 8, 2024 /PRNewswire/ -- Juniper Biologics ("Jun...

2024-01-08 09:00 1270

Juniper Therapeutics Acquires Exclusive Rights for SAR Registration for Anti-Viral COVID-19 Drug from Ping An-Shionogi Hong Kong for Singapore

First drug to show both clinical symptomatic efficacy for five typical Omicron-related symptoms and...

2023-12-22 07:00 2189
Juniper Therapeutics Acquires Exclusive Rights for SAR Registration for Anti-Viral COVID-19 Drug from Ping An-Shionogi Hong Kong for Singapore

Singapore-based Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023 by GHP Healthcare and Pharmaceutical Awards

SINGAPORE, Oct. 24, 2023 /PRNewswire/ -- Juniper Biologics , a g...

2023-10-24 12:00 1196

JUNIPER BIOLOGICS PARTNERS WITH CARIS LIFE SCIENCES® FOR MOLECULAR PROFILING DISTRIBUTION IN SOUTH EAST ASIA

SINGAPORE, Jan. 12, 2023 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd

2023-01-12 13:02 2297

JUNIPER BIOLOGICS WINS M&A AWARD 2022 BY ACQUISITION INTERNATIONAL

Best Cell & Gene Therapy Acquisition 2022: Juniper Biologics/Kolon Life Science SINGAPORE, Dec. 23,...

2022-12-23 09:35 2915

Juniper Biologics Establishes Global Headquarters in Singapore

Juniper Biologics' investment will support the growth and innovation of Singapore's pharmaceutical ...

2022-09-15 09:53 1697

Juniper Biologics Pte. Ltd. signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East*

LUGANO, Switzerland, Sept. 1, 2022 /PRNewswire/ -- Helsinn Group ("Helsinn"), a fully integrated, g...

2022-09-01 17:00 1731

Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets*

LUGANO, Switzerland, and SINGAPORE, May 4, 2022 /PRNewswire/ -- Juniper Biologics Pte Ltd, a scienc...

2022-05-04 14:00 2026

JUNIPER BIOLOGICS ACQUIRES CELL-MEDIATED GENE THERAPY TG-C LD FOR TREATMENT OF KNEE OSTEOARTHRITIS

$600 million USD acquisition will see Juniper Biologics offer the world's first cell-mediated gene ...

2022-04-13 07:57 1622

Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive

SINGAPORE, April 15, 2021 /PRNewswire/ -- Juniper Biologics, a science-led healthcare company focus...

2021-04-15 16:30 2052